Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1909 1
1955 1
1956 2
1957 1
1962 2
1963 1
1964 3
1966 3
1968 6
1969 9
1970 10
1971 8
1972 8
1973 3
1974 11
1975 5
1976 16
1977 17
1978 22
1979 16
1980 16
1981 10
1982 13
1983 9
1984 9
1985 8
1986 5
1987 6
1988 9
1989 5
1990 8
1991 11
1992 6
1993 16
1994 18
1995 12
1996 14
1997 10
1998 18
1999 33
2000 24
2001 23
2002 14
2003 25
2004 17
2005 11
2006 15
2007 19
2008 17
2009 19
2010 15
2011 25
2012 23
2013 19
2014 29
2015 28
2016 30
2017 31
2018 36
2019 51
2020 38
2021 40
2022 44
2023 46
2024 24
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

967 results

Results by year

Filters applied: . Clear all
Page 1
Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.
Gounder M, Ratan R, Alcindor T, Schöffski P, van der Graaf WT, Wilky BA, Riedel RF, Lim A, Smith LM, Moody S, Attia S, Chawla S, D'Amato G, Federman N, Merriam P, Van Tine BA, Vincenzi B, Benson C, Bui NQ, Chugh R, Tinoco G, Charlson J, Dileo P, Hartner L, Lapeire L, Mazzeo F, Palmerini E, Reichardt P, Stacchiotti S, Bailey HH, Burgess MA, Cote GM, Davis LE, Deshpande H, Gelderblom H, Grignani G, Loggers E, Philip T, Pressey JG, Kummar S, Kasper B. Gounder M, et al. Among authors: burgess ma. N Engl J Med. 2023 Mar 9;388(10):898-912. doi: 10.1056/NEJMoa2210140. N Engl J Med. 2023. PMID: 36884323 Free PMC article. Clinical Trial.
Atezolizumab for Advanced Alveolar Soft Part Sarcoma.
Chen AP, Sharon E, O'Sullivan-Coyne G, Moore N, Foster JC, Hu JS, Van Tine BA, Conley AP, Read WL, Riedel RF, Burgess MA, Glod J, Davis EJ, Merriam P, Naqash AR, Fino KK, Miller BL, Wilsker DF, Begum A, Ferry-Galow KV, Deshpande HA, Schwartz GK, Ladle BH, Okuno SH, Beck JC, Chen JL, Takebe N, Fogli LK, Rosenberger CL, Parchment RE, Doroshow JH. Chen AP, et al. Among authors: burgess ma. N Engl J Med. 2023 Sep 7;389(10):911-921. doi: 10.1056/NEJMoa2303383. N Engl J Med. 2023. PMID: 37672694 Free PMC article. Clinical Trial.
Neuroscience Needs Network Science.
Barabási DL, Bianconi G, Bullmore E, Burgess M, Chung S, Eliassi-Rad T, George D, Kovács IA, Makse H, Nichols TE, Papadimitriou C, Sporns O, Stachenfeld K, Toroczkai Z, Towlson EK, Zador AM, Zeng H, Barabási AL, Bernard A, Buzsáki G. Barabási DL, et al. Among authors: burgess m. J Neurosci. 2023 Aug 23;43(34):5989-5995. doi: 10.1523/JNEUROSCI.1014-23.2023. J Neurosci. 2023. PMID: 37612141 Free PMC article.
Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT Trial.
Schmid P, Abraham J, Chan S, Wheatley D, Brunt AM, Nemsadze G, Baird RD, Park YH, Hall PS, Perren T, Stein RC, Mangel L, Ferrero JM, Phillips M, Conibear J, Cortes J, Foxley A, de Bruin EC, McEwen R, Stetson D, Dougherty B, Sarker SJ, Prendergast A, McLaughlin-Callan M, Burgess M, Lawrence C, Cartwright H, Mousa K, Turner NC. Schmid P, et al. Among authors: burgess m. J Clin Oncol. 2020 Feb 10;38(5):423-433. doi: 10.1200/JCO.19.00368. Epub 2019 Dec 16. J Clin Oncol. 2020. PMID: 31841354 Free article. Clinical Trial.
Neuroscience needs Network Science.
Barabási DL, Bianconi G, Bullmore E, Burgess M, Chung S, Eliassi-Rad T, George D, Kovács IA, Makse H, Papadimitriou C, Nichols TE, Sporns O, Stachenfeld K, Toroczkai Z, Towlson EK, Zador AM, Zeng H, Barabási AL, Bernard A, Buzsáki G. Barabási DL, et al. Among authors: burgess m. ArXiv [Preprint]. 2023 May 11:arXiv:2305.06160v2. ArXiv. 2023. Update in: J Neurosci. 2023 Aug 23;43(34):5989-5995. doi: 10.1523/JNEUROSCI.1014-23.2023 PMID: 37214134 Free PMC article. Updated. Preprint.
Immunotherapy in Sarcoma: Future Horizons.
Burgess M, Gorantla V, Weiss K, Tawbi H. Burgess M, et al. Curr Oncol Rep. 2015 Nov;17(11):52. doi: 10.1007/s11912-015-0476-7. Curr Oncol Rep. 2015. PMID: 26423769 Review.
A Single-Arm Phase 2 Trial of Trametinib in Patients with Locally Advanced or Metastatic Epithelioid Hemangioendothelioma.
Schuetze SM, Ballman KV, Heise R, Ganjoo KN, Davis EJ, George S, Burgess MA, Choy E, Shepard DR, Tinoco G, Hirbe A, Kelly CM, Attia S, Deshpande HA, Schwartz GK, Siontis BL, Riedel RF, von Mehren M, Kozlowski E, Chen HX, Astbury C, Rubin BP. Schuetze SM, et al. Among authors: burgess ma. Clin Cancer Res. 2024 Oct 15;30(20):4584-4592. doi: 10.1158/1078-0432.CCR-23-3817. Clin Cancer Res. 2024. PMID: 38446990 Clinical Trial.
ALX4::NCOA2 rearranged round and spindle cell sarcoma.
Zilla ML, Korentzelos D, Lebamoff J, Burgess MA, Naous R, John I. Zilla ML, et al. Among authors: burgess ma. Histopathology. 2024 Jul;85(1):201-204. doi: 10.1111/his.15189. Epub 2024 Apr 2. Histopathology. 2024. PMID: 38566331 No abstract available.
Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial.
Mowery YM, Ballman KV, Hong AM, Schuetze SM, Wagner AJ, Monga V, Heise RS, Attia S, Choy E, Burgess MA, Bae S, Pryor DI, Van Tine BA, Tinoco G, Chmielowski B, Freeman C, Gronchi A, Meyer CF, Dickson MA, Hartner L, Davis LE, Powers BC, Moding EJ, Weinhold KJ, van de Rijn M, Brigman BE, Riedel RF, Kirsch DG. Mowery YM, et al. Among authors: burgess ma. Lancet. 2024 Nov 23;404(10467):2053-2064. doi: 10.1016/S0140-6736(24)01812-9. Epub 2024 Nov 12. Lancet. 2024. PMID: 39547252 Clinical Trial.
967 results